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We used a double-label immunofluorescence assay to examine the ability of Chiamydia trachomatis serovar
F to infect and develop within HeLa 229 cells previously infected with serovar E. No exclusion to superinfection
occurred for up to 24 h following infection by serovar E. The percentage of HeLa cells infected in cultures
inoculated with both strains was identical to that of cells in cultures inoculated with one strain as a control.
Organisms of both serovars were located within the same intracellular inclusion in 88 to 95% of HeLa cells
infected with both serovars. The proportion of superinfected HeLa cells containing both strains in separate
inclusions increased when there was exposure to inhibitors of cytoskeletal structure and transport. We used this
inhibition to demonstrate that fusion of C. trachomatis phagosomes occurs throughout the developmental cycle.
The intracellular parasites of the genus Chlamydia have a
distinctive intracellular developmental cycle. Following at-
tachment and ingestion by the host cell, the infectious
elementary body (EB) differentiates to the metabolically
active reticulate body (6, 16). The reticulate body undergoes
replication by binary fission within an intracellular phago-
some, which is bounded by membrane initially derived from
the host cell. After numerous replicative divisions of the
reticulate bodies, the phagosome becomes visible as the
chlamydial inclusion. By an unknown mechanism, perhaps
mediated through the chlamydial outer membrane, the chla-
mydial phagosome avoids fusion with host cell lysosomes
(5). Thus, avoidance of phagosome-lysosome fusion may be
critical to the intracellular survival of chlamydiae.
In contrast to cells infected in vitro by Chlamydia psittaci
organisms (11, 16), mammalian cells infected by C. tracho-
matis usually contain only one chlamydial inclusion, even
under high multiplicities of infection (2, 3). This suggests
that, for C. trachomatis, either multiple infecting EBs are
excluded from infection following initial infection by one
organism (superinfection exclusion) or phagosomes from
multiple infecting organisms may coalesce during the devel-
opment of the organism. Prior microscopic studies of C.
trachomatis suggested that concurrent infection of a single
host cell by multiple EBs of the same serovar could occur
and that coalescence of phagosomes probably accounted for
the failure to observe multiple inclusions late in the infective
cycle (2, 3).
C. trachomatis has been classified with monoclonal anti-
bodies into more than 15 serovars (22). The epitopes deter-
mining serovar specificity reside predominantly on the major
outer membrane protein (20). Recently, we reported in-
stances of clinical infection by multiple serovars of C.
trachomatis (1). Coinfection of a single epithelial cell by two
strains of C. trachomatis with subsequent coalescence of
endosomes could bring chlamydial organisms into close
* Corresponding author.
t Present address: Division of Public Health, Office of Laborato-
ries, Dover, DE 19903.
t Present address: Consultants in Medicine, 800 E. Chestnut St.,
Bellingham, WA 98225.
contact; this might then allow genetic exchange leading to
serological diversity. Thus, studies of the fate of different C.
trachomatis strains infecting the same host cell can provide
information regarding possible mechanisms of phagosomal
membrane fusion and potential mechanisms for genetic
exchange. We employed serogroup-specific monoclonal an-
tibodies with double-label immunofluorescence microscopy
to study the intracellular development of superinfected
HeLa 229 cells. We found that prior infection does not
influence superinfection with another serovar of C. tracho-
matis during the first 24 h following the initial infection and
that fusion of chlamydial phagosomes occurs throughout the
intracellular developmental cycle.
(This work was presented in part at the 87th Annual
Meeting of the American Society for Microbiology, Atlanta,
Ga., 1 to 6 March 1987 [D-156, p. 98].)
MATERIALS AND METHODS
HeLa 229 cells. The HeLa 229 cells and C. trachomatis
strains were kindly provided by C.-C. Kuo, Department of
Pathobiology, University of Washington. Monolayers of
HeLa cells were grown in 150-cm2 tissue culture flasks at
37°C and were transferred two to three times weekly. The
growth medium was Eagle minimal essential medium sup-
plemented with 10% fetal bovine serum (Hyclone Laborato-
ries, Logan, Utah), 2 mM L-glutamine, 2% nonessential
amino acids, and 10 mM HEPES (N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid) buffer (all from GIBCO Lab-
oratories, Grand Island, N.Y.). Cells were maintained with-
out antibiotics until they were inoculated with chlamydiae.
Cells were tested for mycoplasma contamination periodi-
cally by 4-6-diamidino-2-phenylindole staining (Sigma
Chemical Co., St. Louis, Mo.) (4) and culture (Flow Labo-
ratories, Inc., McLean, Va.).
C. trachomatis. The genital isolates E/UW-5/Cx and F/
UW-6/Cx were passed at least 10 times in HeLa 229 cells
before being used in these experiments. C. trachomatis
strains were cultivated in HeLa 229 cells treated with
DEAE-dextran (14) in HSC buffer (10 mM HEPES, 0.2 M
sucrose, 0.09 M NaCl, 1 x 10-3 M MgCl2, 1.5 x 10-4 M
CaCl2). EBs were harvested 72 h after inoculation, partially
purified by differential centrifugation in HSC, and pelleted
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through a 35% Renografin-76 (Squibb Diagnostics, New
Brunswick, N.J.) cushion (13). The pelleted EBs were then
washed in HSC, repelleted as described above, suspended in
HSC, divided into aliquots of 0.5 ml, and stored in vapor-
phase liquid nitrogen.
Monoclonal antibody reagents. Monoclonal antibodies to
C. trachomatis KB8 (serovars E/L1 specific) and FC2 (se-
rovar F specific) have been described previously (22). Anti-
bodies were purified from murine ascites by protein A-
Sepharose affinity chromatography (Pharmacia, Uppsala,
Sweden). Antibody KB8 was conjugated to sulforhodamine
(Texas Red; Molecular Probes, Inc., Junction City, Oreg.)
according to the instructions of the manufacturer. Antibody
FC2 was conjugated to fluorescein (FITC-FC2), using fluo-
rescein isothiocyanate in basic aqueous solution by standard
methods (8).
Superinfection. Monolayers of HeLa cells were inoculated
with chlamydial strains 24 to 36 h after plating. C. tracho-
matis serovar E was inoculated onto host cell monolayers in
96-well microdilution plates that were rocked for 1 h at 35°C.
The inoculum was then removed, the monolayer was rinsed
with phosphate-buffered saline, and growth medium was
added. The infected HeLa cells were incubated at 35°C for
various times before superinfection. To superinfect, growth
medium was aspirated from the infected HeLa cell mono-
layer. The monolayer was then washed as before, and the
inoculum of serovar F in HSC buffer was added. Infection
with serovar F was allowed to proceed for 1 h at 37°C at 1 x
g; then monolayers were washed twice with phosphate-
buffered saline. The HeLa cells were then detached with
0.02% trypsin in phosphate-buffered saline and replated onto
12-mm glass cover slips in shell vials containing growth
medium such that individual cells could be distinguished
microscopically (12). Single-infection controls for both sero-
vars were treated as superinfected cells with HSC buffer
added in place of the primary or secondary inoculum. Shell
vials were incubated at 37°C for 24 or 48 h following
superinfection. Cover slips were fixed with methanol,
stained with a mixture of FITC-FC2 and antibody KB8
conjugated to sulforhodamine for 1 h, rinsed in phosphate-
buffered saline and distilled water, and mounted on slides
with 10% glycerol and N-propyl gallate (7). Slides were
examined with a Zeiss standard fluorescence microscope
equipped with a x63 Neofluor oil immersion objective and a
sliding mount containing Texas Red and FITC filter cubes.
In randomly selected fields, 200 cells were counted on each
cover slip and classified as uninfected, E infected, F in-
fected, or E and F infected.
Microtubule and microfilament inhibitors. Cytochalasins B
and D, colchicine, vincristine, and vinblastine were dis-
solved in dimethyl sulfoxide and added to growth medium at
final concentrations of 1.0 and 2.5 ,ug/ml for cytochalasins B
and D, 2.5 and 5.0 ,ug/ml for vincristine and vinblastine, and
1.0 and 2.0 ,ug/ml for colchicine. In experiments to test the
effect of inhibitors on HeLa cell infection, the inhibitors
were added to HeLa cells 1 h before superinfection and
maintained in the growth medium until fixation and staining
of the cell layer. All cells were superinfected with serovar F
4 h after infection with serovar E, then incubated 48 h before
staining. Single-infected and superinfected untreated cells
were included as controls. Duplicates of each control were
superinfected in growth medium without cycloheximide to
measure the effect of cycloheximide on superinfection. Du-
plicate wells were tested for cell viability with trypan blue
(Sigma) staining. More than 95% of the cells were viable in
TABLE 1. Percentage of HeLa cells containing inclusions
following infection by C. trachomatis serovars E and F,
with serovar F added at various times following
infection with serovar E
% Cells infecteda for indicated h
Serovar observed of superinfection
(serovar added)
0 1 2 4 8 24
E (E and F added) 71.2 66.9 68.9 70.8 70.8 62.8
F (E and F added) 30.8 27.9 32.6 25.3 24.8 30.2
Both (E and F added) 24.6 22.8 25.8 21.1 20.7 22.1
E (only E added) 70.6 70.2 72.0 77.7 72.3 69.3
F (only F added) 33.0 31.7 28.4 22.5 26.2 32.7
a Percentages are the averages of three experiments, with four replicate
wells with 200 cells counted per well for each experiment. The average
coefficient of variation is 10.8%.
each microtubule or microfilament inhibitor control vial after
48 h of incubation.
In experiments to examine the kinetics of phagosome
fusion, HeLa cells were infected with serovar E and super-
infected with serovar F 4 h later. At various times thereafter,
cytochalasin D (2.5 ,ugIml) was added to the growth medium
to inhibit further fusion of phagosomes. At 48 h after
superinfection, cells were fixed, stained with monoclonal
antibody mixture, and counted.
RESULTS
Superinfection. Infection of HeLa 229 cells by C. tracho-
matis serovar F occurred in similar proportions for cells
infected by serovar E as well as controls (Table 1). The
proportions of cells infected by each serovar were also
similar for superinfected cells and single-infection controls.
By using our standard EB preparations, serovar E infected
69% + 3% of all cells counted versus 71% + 3% for controls,
while serovar F infected 29% + 4% for both superinfected
and single-infected cells (mean plus standard deviation for
three separate experiments). The proportion of cells infected
by each serovar following superinfection was independent of
time of superinfection for at least 24 h. The addition of
cycloheximide to the growth medium increased the number
of cells infected by either serovar but did not change the
distribution of phagosome morphologies following superin-
TABLE 2. Effect of cycloheximide on superinfection
of HeLa cells
Mean % cells infected + SDa
Serovar in single or
double infection Cycloheximide No cycloheximide
added added
Single infection
E 77.3 ± 4.9 39.4 ± 4.5
F 23.0 ± 1.4 9.2 ± 3.4
Double infection
E 74.7 ± 3.2 38.0 ± 3.5
F 26.4 ± 3.7 10.4 ± 2.2
E + F 23.0 ± 2.9 8.2 ± 2.5
E + F/Fb 87.5 ± 4.0 78.1 ± 9.2
E + F separatec 1.2 ± 1.4 3.9 ± 4.7
a Mean plus or minus standard deviation of four replicate wells with 200 cells
counted per well. Cells were incubated in growth medium with or without 1 jLg
of cycloheximide per ml added after initial infection and superinfection.
b F-infected cells that also contained serovar E.
c Coinfected cells with the superinfecting F serovar in a separate inclusion.
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fection (Table 2). The proportion of superinfected cells (E +
F) reflected a high percentage of all serovar F-infected cells
(E + F/F) with (87.5%) or without (78.1%) cycloheximide.
Two morphologic forms of chlamydial phagosomes were
FIG. 1. (a and b) Superimposable photomicrographs of the same
microscopic field of several HeLa cells which were stained with
antibodies to both serovars E and F. (a) This photomicrograph was
taken using FITC optics, which visualizes inclusions of serovar F;
(b) this was taken with Texas Red optics, which visualizes inclu-
sions of serovar E. Two of the inclusions seen contain both serovars
E and F, and one (middle) contains only serovar F.
FIG. 2. Photomicrograph of a microscopic field of HeLa cells
stained with antibodies to both serovars E and F and photographed
with double exposure using first FITC and then Texas Red optics.
The cell at the top contains both serovars, at opposite poles of the
host cell, and the cell just below it contains both serovars in the
same inclusion.
observed within superinfected HeLa 229 cells at 48 h. The
predominant form (>95% of cells infected by both serovars)
consisted of a single inclusion containing EBs of both
serovars (Fig. 1 and 2). Less frequently, two separated
inclusions, each containing EBs of one serovar, were seen.
The proportion of cells with a single inclusion containing
both serovars was greater if superinfected cells were stained
at 48 h following superinfection (>95%) than if they were
stained 24 h following superinfection (87%).
Effect of cytoskeletal inhibitors on superinfection. The
microfilament inhibitors cytochalasins B and D and the
microtubule inhibitors colchicine, vincristine, and vinblas-
tine had different effects on the efficiency of superinfection
and on the proportion of superinfected cells exhibiting
phagosomes that contained both serovars (Table 3). When
inhibitors were added 1 h before superinfection, the infection
by serovar F was relatively unaffected for infections in the
presence of colchicine, vincristine, and cytochalasin B but
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TABLE 3. Effect of microtubule or microfilament inhibitors on
the proportion of cells infected with C. trachomatis
serovars E and F
Mean % cellsa infected by:
Inhibitor E + F
EF E + F (separate)b
Control 74.7 26.4 23.1 1.2
Colchicine 79.2 21.1 17.9 12.3
Vincristine 76.8 21.5 17.3 14.2
Vinblastine 79.9 16.7 15.7 21.5
Cytochalasin B 74.0 21.2 17.0 8.8
Cytochalasin D 70.1 4.7 3.0 50.0
a Mean of duplicate wells with 200 cells counted per well.
b Percentage of coinfected cells (E + F) that contained each serovar in a
separate phagosome.
was substantially reduced in the presence of vinblastine or
cytochalasin D at 2.5 ,ug/ml. All inhibitors increased the
proportion of coinfected cells in which the serovar E and F
phagosomes were separated; the greatest effect was noted
with cytochalasin D.
Figure 3 illustrates the effect of adding cytochalasin D at
various times following superinfection. The proportion of
cells with single phagosomes containing both serovars in-
creased continuously throughout the developmental cycle. A
decrease in infectivity as measured by total numbers of cells
infected was not detected when cytochalasin D was added
after superinfection (data not shown).
DISCUSSION
Moulder and co-workers (17) found that mouse L cells
persistently infected with C. psittaci organisms were resis-
tant to superinfection with the same strain. Demonstrating
such latent, persistent infection and superinfection exclusion
has been more difficult with C. trachomatis (15). Under
conditions of infection dramatically different from those
used to establish persistence in the previously cited studies,
we have found that prior productive infection of HeLa cells
by a strain of one C. trachomatis serovar does not exclude













Time of cytochalasin D addition (Hours)
FIG. 3. Chart showing proportion of coinfected cells containing
two phagosomes with differing serovars. At various times after
superinfection (horizontal axis), cytochalasin D was added to repli-
cate cultures to prevent further fusion of chlamydial phagosomes.
tion confirms and extends earlier findings suggesting that
multiple C. trachomatis phagosomes fuse at some time
following infection (2, 3). In our studies, superinfection of
HeLa cells resulted in single inclusions containing EBs of
both serovars. Previous studies have noted single inclusions
in cells infected with a single serovar, even when high
multiplicities of infection favored the ingestion of more than
one organism (2, 3). Our findings suggest either that multiple-
infecting chlamydial EBs are transported to the same pha-
gosome at the time of ingestion, or shortly thereafter, or that
multiple-infecting organisms could reside within individual
phagosomes which fuse when approximated by cytoplasmic
flow throughout the chlamydial developmental cycle.
The inhibition of phagosomal fusion, but not infectivity,
by adding cytochalasin D after superinfection demonstrated
that fusion of chlamydial phagosomes is a microfilament-
dependent process distinct from ingestion of the agent. The
ability of cytochalasin D to inhibit inclusion formation by the
F serovar when added before superinfection agrees with the
findings of Ward and Murray (23) that this drug affects the
initial steps of attachment and endocytosis.
Our observation that cultured mammalian cells can be
coinfected by different chlamydial serovars has theoretical
relevance to the ontogeny of oculogenital infection in hu-
mans and to the evolution of serovars of the organism. The
ability of organisms of different antigenic structure to infect
the same host cell may provide a mechanism for exchange of
structural determinants, explaining the serologic diversity of
the major outer membrane protein. Until genetic markers are
identified for C. trachomatis, this hypothesis remains purely
speculative.
Ultrastructural studies (10, 23) suggest that the fusion of
C. trachomatis phagosomes occurs very shortly after infec-
tion. These previous studies, however, used high multiplic-
ities of infection (ca. 1,000:1) to bring individual endocy-
tosed EBs into close proximity for better observation in
electron microscopy sections. Our study, using lower mul-
tiplicities of infection (ca. 10:1), indicates that phagosomal
fusion occurs throughout the intracellular developmental
cycle and may reflect a phenomenon separate from the
intracellular sorting associated with receptor-mediated en-
docytosis. Our results do not indicate whether the fusion of
endocytic vesicles containing C. trachomatis is a result of
random collisions or is directed by cellular mechanisms of
cytoplasmic flow.
There are conflicting studies on the mechanism of attach-
ment and ingestion of chlamydial organisms. Some studies
support a classic receptor-mediated attachment and inges-
tion model (10, 11, 18, 19), whereas a zipper mechanism of
ingestion has been suggested by some ultrastructural studies
(23). In other experimental models of receptor-mediated
endocytosis, an attached ligand is lateralized to clathrin-
coated pits and ingested in multiple endosomes which fuse
within several minutes in metabolically active cells at 37°C
(9, 21). Thus, observation of prompt coalescence of infecting
particles in this study would have indirectly supported the
hypothesis of receptor-mediated endocytosis in chlamydial
ingestion. Our experimental system cannot accurately iden-
tify individual EBs at very early times following superinfec-
tion; thus, our results provide no direct information regard-
ing chlamydial attachment and ingestion.
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